Catalyst Healthcare Sells Arkansas MOB

Catalyst Healthcare Real Estate has sold Kanis Medical Plaza, a 37,862-square-foot medical outpatient facility in Little Rock, Ark. Laramar Group acquired the asset in a deal brokered by CBRE.

The four-story building previously traded in January 2022, according to Yardi Matrix information. Flake & Co. sold it at the time for $10.1 million—almost $267 per square foot.

The 2004-completed facility is at 9101 Kanis Road, adjacent to Baptist Health’s 827-bed flagship hospital, the largest in the state. The property is close to Interstate 430 and within 6 miles from downtown Little Rock. Other medical providers in the area include Arkansas Heart Hospital and Arkansas Allergy & Asthma Clinic.

---

READ ALSO: Medical Office Real Estate Trends

---

Services at Kanis Medical Plaza include imaging, rheumatology, OB/GYN and pain management. At the time of sale, the building was fully leased to five tenants, among which was a health system investment-grade credit with Baptist Health Arkansas, the largest not-for-profit healthcare organization in the state.

CBRE Vice Chair Chris Bodnar, Executive Vice President Brannan Knott, Senior Vice Presidents Zack Holderman, William Callahan and Anthony Sardo, along with First Vice President Cole Reethof and Vice President Jesse Greshin, brokered the deal on behalf of the seller.

MOB sector maintains momentum

The medical office building sector continues to post solid fundamentals, supported by an aging population, expanding outpatient care and a constrained development pipeline, according to a JLL report. With new supply limited and outpatient services shifting into increasingly specialized facilities, landlords have maintained pricing power, pushing occupancy higher.

On the capital markets side, investor appetite for medical office remains strong, reinforced by steady cash flows and improving operating metrics. Looking ahead, stronger debt availability and stable fundamentals could support higher transaction volume in 2026, though pricing and underwriting will remain sensitive to policy changes and reimbursement pressures.